Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanjing Zhongke Group is a prominent Chinese high-tech enterprise specializing in the research, development, and production of health supplements and traditional Chinese medicine (TCM). Established in 1984 and originating from the Chinese Academy of Sciences, the company is a leader in the Ganoderma lucidum (Lingzhi) industry, particularly known for its spore oil and powder products. Their business model integrates scientific research, cultivation, manufacturing, and sales, focusing on immune enhancement and adjuvant therapies for chronic diseases. The group maintains a significant market presence in China and exports products to various international markets, emphasizing the modernization and standardization of herbal medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanjing Zhongke Group.